** Shares in cancer biotech company eFFECTOR Therapeutics
EFTR.O up 138.9% at $30.65 after rising to a high of $40.42 as
volumes jumped sharply
** On Aug 26., co began trading under EFTR ticker and closed
that session at $15.21. Blank-check company Locust Walk, then
trading as LWAC, announced on Aug. 25 that its stockholders
voted in favor of a proposed buyout of eFFECTOR urn:newsml:reuters.com:*:nGNX1mQ7vT
** After falling in the following six sessions, EFTR
suddenly shot higher on Tues Sept. 7 when it gained 49.9% in one
session with 7.7 mln shares changing hands
** So far on Wednesday, 33.1 mln shares had changed hands
vs free float of 39.78 mln shares and total shares outstanding
of 40.67 mln, according to Refinitiv data
** EFTR representatives did not immediately return a request
for comment
** Investors using the Stocktwits.com social media forum
were taking notice, with EFTR representing the second busiest
trending stream
(Reporting By Sinéad Carew)
((sinead.carew@thomsonreuters.com; +1 (646) 223 6186; Reuters
Messaging: sinead.carew.thomsonreuters.com@reuters.net))